Holding(s) in Company

Dechra Pharmaceuticals PLC 24 February 2006 Dechra Pharmaceuticals PLC ('the Company') Holding(s) in Company The Company was notified 23 February 2006 by Barclays PLC that through the legal entities of Barclays Global Investors Ltd, Barclays Capital Securities Ltd, Barclays Life Assurance Co Ltd and Gerrard Ltd, Barclays PLC has a notifiable interest in 3,102,537 ordinary shares of 1p each in the Company ('Ordinary Shares'), representing approximately 6.03 per cent. of the Company's issued ordinary share capital. These Ordinary Shares are registered as follows: Registered Holder Ordinary Shares Barclays Capital Nominees Limited 590,171 Chase Nominees Ltd a/c 16376 28,830 Chase Nominees Ltd a/c 21359 162,359 Chase Nominees Ltd a/c 28270 30,304 Chase Nominees Ltd a/c 28270 18,742 JP Morgan (BGI Custody) a/c 16341 77,540 JP Morgan (BGI Custody) a/c 16341 36,065 JP Morgan (BGI Custody) a/c 16344 26,567 JP Morgan (BGI Custody) a/c 16345 44,263 JP Morgan (BGI Custody) a/c 16400 386,797 JP Morgan (BGI Custody) a/c 16480 1,425,499 JP Morgan (BGI Custody) a/c 16482 244,540 JP Morgan (BGI Custody) a/c 18409 29,412 R C Greig Nominees Limited a/c 1,448 Total 3,102,537 24 February 2006 This information is provided by RNS The company news service from the London Stock Exchange D HOLKGGZZGDZGVZM
UK 100

Latest directors dealings